Richmond, VANCT06718686Now EnrollingIRB Ready

Dementia Alzheimer Type Clinical Trial in Richmond, VA

Access cutting-edge dementia alzheimer type treatment through this clinical trial at a research site in Richmond. Study-provided care at no cost to qualified participants.

Sponsored by Jasmohan Bajaj

Quick Self-Assessment

See if you qualify for this Richmond location

Preparing your pre-screening questions…

Expert Care in Richmond

Access dementia alzheimer type specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related dementia alzheimer type treatment provided free

Apply for This Richmond Location

Check if you qualify for this dementia alzheimer type clinical trial in Richmond, VA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Richmond

    Convenient for VA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Richmond site if eligible
  4. 4Begin participation

About This Dementia Alzheimer Type Study in Richmond

Using a new formulation of rifaximin, a non-absorbable antibiotic, to test if it can affect microbes in the gut of patients with dementia favorably.

Sponsor: Jasmohan Bajaj

Who Can Participate

Inclusion Criteria

Probable Alzheimer's Disease (AD) or Vascular Dementia (VaD) mild or moderate based on Clinical Dementia Rating Scale.
Males and Females Age ≥ 65 years
Community living with availability of caregiver to accompany participant to study visits and to participate in the study.
Able to consent or legal guardian who can consent (with participant assent).
Legally authorized representative (LAR) and caregiver for the study is the same individual.
Fluency (both participant and caregiver) in written and spoken English to participate in study visits.

Exclusion Criteria

Dementia not due to AD or VaD
Clinically significant agitation or aggression (requiring treatment with antipsychotic medication)
Delusions and/or hallucinations
Severe psychopathology including major depression
Unstable, severe, or poorly controlled medical conditions evident from physical examination or clinical history
Visual and/or hearing disorder that prevents completion of neuropsychologic evaluations.
Hypersensitivity to rifaximin, components of rifaximin,
and any rifamycin antimicrobial agent
Antibiotic use in the prior 6 months
Taking medications that interact with Rifaximin. P-glycoprotein (P-gp) inhibitor treatment is permitted as long as the use of P-gp inhibitors is discussed with the investigator.
History of alcohol and/or drug abuse
Participation in another investigational drug trial in the last 30 days

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Richmond?

Yes, this clinical trial (NCT06718686) has an active research site in Richmond, VA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Dementia Alzheimer Type Treatment Options in Richmond, VA

If you're searching for dementia alzheimer type treatment options in Richmond, VA, this clinical trial (NCT06718686) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Richmond research site is actively enrolling participants for this clinical trial. You'll receive care from experienced dementia alzheimer type specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all dementia alzheimer type clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Richmond, VA

See all pulmonary embolism clinical trials recruiting in Richmond — not just this study.

Browse Pulmonary Embolism Trials in Richmond →

Browse More Trials by Condition

Pulmonary Embolism TrialsAlzheimers Disease TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Richmond?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Richmond, VA